相关实验视频
Updated: Jun 10, 2025
07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
147
由败血症复杂的心力衰竭的生存预测:基于机器学习方法
Qitian Zhang1, Lizhen Xu2, Weibin He1
1Department of Cardiology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China.
Frontiers in medicine
|October 18, 2024
概括
一种新的后勤回归 (LR) 模型有效预测心力衰竭和败血症患者的28天死亡率. 这种工具有助于临床医生识别高风险个体,以便更好地分配资源和改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 医疗信息学 医疗信息学
背景情况:
- 心力衰竭和败血症显著增加死亡风险.
- 早期识别高风险患者对于资源分配至关重要.
研究的目的:
- 为患有并发性心力衰竭和败血症的患者开发和验证生存预测模型.
- 在这个患者群体中确定28天全因死亡率的关键预测因素.
主要方法:
- 使用eICU-CRD数据库进行模型开发 (3891名患者) 和MIMIC-IV数据库进行外部验证 (2928名患者).
- 采用Boruta方法进行特征选择和XGBoost进行特征排名.
- 进行对比后勤回归 (LR),XGBoost,AdaBoost和高斯天真贝叶斯 (GNB) 模型.
- 使用AUC,精度,灵敏度和特异性评估模型性能;使用SHAP进行解释性.
主要成果:
- 该LR模型表现出卓越的性能,验证AUC为0.746.
- 关键预测因素包括年龄,通风,北上腺素,白细胞计数,总 bilirubin,温度,烯,呼吸速率,中性粒细胞计数和静脉血压.
- 使用MIMIC-IV进行外部验证时,AUC值为0.699.
结论:
- 一个强大的基于LR的模型准确地预测了败血症心力衰竭患者的28天死亡率.
- 该模型为临床医生提供了一种有价值的工具,以识别高风险患者并指导临床实践.
相关概念视频
01:30Heart Failure V: Medical Management
1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
1
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1
01:29Heart Failure II: Pathophysiology
1
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1
01:30Heart Failure V: Nursing Interventions
1
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
1
01:22Heart Failure VI: Adjunct Therapies
1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1